Market Research Logo

Colombia Pharmaceuticals and Healthcare Report Q2 2015

123 Pages BMI Research February 11, 2015 SKU: BMI5466924

Colombia Pharmaceuticals and Healthcare Report Q2 2015

BMI View: President Juan Manuel Santos continues to push forward healthcare reform for medicine pricecontrols and regulatory reformation. Though, such reforms still leave scepticism as Colombia's strugglingeconomy and expanding counterfeit drug market continue to hinder progress for the Colombian governmentand pharmaceutical market.

Headline Expenditure Projections

Pharmaceuticals: COP8,643bn (USD4.38bn) in 2014 to COP9,118bn (USD4.3bn) in 2015; +5.5% inlocal currency terms and -2.1% in US dollar terms. Local currency forecast revised upward from Q115due to increased inflation and currency depreciation. US dollar forecast revised downward from Q115due to increased Colombian inflation and currency depreciation.

Show Full Description


Show Table of Contents



Colombia Pharmaceuticals and Healthcare Report Q2 2015

BMI Research
February 11, 2015

Pricing & Delivery

Report with 3 quarterly updates
$1,295
Report with 3 quarterly updates - 3 User License
$1,945
Report with 3 quarterly updates - 5 User License
$2,500
Report with 3 quarterly updates - Departmental/Site License
$2,995
Global Site License Fulfilled by Publisher
$6,995

Didn't find what you are looking for?

Let us find it for you. One of our knowledgeable research assistants will work with you to find exactly the right research to answer your questions:

US: 800.298.5699 International: +1.240.747.3093 Or leave us a message and we'll call you back!

Receive bi-weekly email alerts for new market research.



CTA Image

Download our free eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.


Download CTA

Share this report